NCT06605404ClinicalTrials.gov
Pan-tumor MRD Study
Molecular Residual Disease in Solid Tumors: A Prospective Study to Collect Clinical Data and Biospecimens to Support Discovery and Development of Cancer Biomarkers
בקצרה
The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to…
תצפיתידרושים 1,350 משתתפים47 אתריםמדינה אחת
קטגוריות
רשום במרשם אחד
- ClinicalTrials.govNCT06605404פתיחת רשומה זו ב־ClinicalTrials.govסונכרן לפני חודשיים
מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.
מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.
מתעניינים במחקר הזה?
התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2024-09-20; recorded start 2025-01-08
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Not stated: No other studies from this sponsor are in this databaseCounted from the lead sponsor named in the record (Paradigm Health)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 7 conditions.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 2 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 1,350 participants (target), run at 47 sites.
How this score is built
- Enrolment31/40
1,350 participants (target)
- Site count4/25
2 sites
- Country count0/15
Single country
- Planned duration10/10
Planned over about 88 months
- Sponsor scale0/10
Paradigm Health has led 1 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
תקציר
The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back. Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.
מצבים רפואיים
- Muscle Invasive Bladder Urothelial Carcinoma
- Esophageal Cancer
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Melanoma (Skin Cancer)
- NSCLC (Non-small Cell Lung Cancer)
- Pancreatic (Exocrine Only)
- Mix of Solid Tumors (MOST)
זכאות
| מין | הכול |
|---|---|
| גילאים | 18 Years – ללא מקסימום |
| מתנדבים בריאים | לא |
| שיטת דגימה | NON_PROBABILITY_SAMPLE |
אוכלוסיית המחקר
Study participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors
זכאות כפי שנכתבה במרשם
זכאות במשפטים פשוטים
הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.
תכנון המחקר
| סוג המחקר | תצפיתי |
|---|---|
| שלב | לא צוין ברשומת המרשם |
| הקצאה | לא צוין ברשומת המרשם |
| מודל ההתערבות | לא צוין ברשומת המרשם |
| מטרה ראשית | לא צוין ברשומת המרשם |
| הסתרה | לא צוין ברשומת המרשם |
| גיוס | דרושים 1,350 משתתפים |
נותן חסות ושותפים
- Paradigm Health נותן חסות
זרועות והתערבויות
- Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)
Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)
- Esophageal
Esophageal cancer
- Gastric and Gastroesophageal Junction (GEJ)
Gastric and Gastroesophageal Junction (GEJ)
- Melanoma
Melanoma
- Non-small cell lung (NSCLC)
Non-small cell lung (NSCLC)
- Pancreatic (exocrine only)
Pancreatic (exocrine only)
- Mix of Solid Tumors (MOST)
Mix of Solid Tumors (MOST)
התערבויות
- בדיקה אבחנתית blood and tissue samples
routine standard of care
- אחר blood and tissue samples
Routine standard of care
מדדי תוצאה
מדד תוצאה ראשוני
Blood and tissue biospecimen registry
To establish a blood and tissue biospecimen resource in participants with operable solid tumors, with clinical, lab, radiographic, and pathology annotation for the discovery, development, and validation of MRD assays.
מסגרת זמן Observation from enrollment to 5.5 years after enrollment
תאריכים
| תאריך התחלה | 8 בינואר 2025 (בפועל) |
|---|---|
| סיום ראשוני | 1 בדצמבר 2031 (משוער) |
| סיום | 1 באפריל 2032 (משוער) |
| פורסם לראשונה | 20 בספטמבר 2024 (בפועל) |
| עודכן לאחרונה | 24 בספטמבר 2026 |
| התוצאות פורסמו | לא צוין ברשומת המרשם |
| המצב אומת לאחרונה | ספטמבר 2026 |
בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.
מיקומים
47 אתרים מגייסים
United States
| מתקן | עיר | מדינה או אזור | מצב |
|---|---|---|---|
| Piedmont Cancer Institute | Atlanta | Georgia | מגייס |
| Guthrie Lourdes Memorial Hospital (GLMH) | Binghamton | New York | מגייס |
| Alabama Oncology | Birmingham | Alabama | מגייס |
| Mohtaseb Cancer Center and Blood Disorders | Bullhead City | Arizona | מגייס |
| Gabrail Cancer Center | Canton | Ohio | מגייס |
| Cancer & Blood Specialists of Arizona | Casa Grande | Arizona | מגייס |
| Carolina Oncology Specialists | Charlotte | North Carolina | מגייס |
| Oncology & Hematology Associates of West Broward | Coral Springs | Florida | מגייס |
| Baptist Health Corbin | Corbin | Kentucky | מגייס |
| Pontchartrain Cancer Center | Covington | Louisiana | מגייס |
| Baptist Health Hardin | Elizabethtown | Kentucky | מגייס |
| The Melanoma and Skin Cancer Institute | Englewood | Colorado | מגייס |
| San Juan Oncology Associates | Farmington | New Mexico | מגייס |
| Los Angeles Cancer Network (LACN) | Glendale | California | מגייס |
| Southeastern Medical Oncology Center (SMOC) | Goldsboro | North Carolina | מגייס |
| The Cancer & Hematology Centers (CHC) | Grand Rapids | Michigan | מגייס |
| Onocology Consultants P.A. (Oncology Consultants [OC Houston]) | Houston | Texas | מגייס |
| Community Clinical Trials | Kingwood | Texas | מגייס |
| Lancaster General Hospital (UPenn) | Lancaster | Pennsylvania | מגייס |
| Baptist Health Lexington | Lexington | Kentucky | מגייס |
| Cancer Partners of Nebraska | Lincoln | Nebraska | מגייס |
| CARTI | Little Rock | Arkansas | מגייס |
| Baptist Health Louisville | Louisville | Kentucky | מגייס |
| Taylor Cancer Research Center | Maumee | Ohio | מגייס |
| Cancer Care Specialists of Illinois (CCSI) | O'Fallon | Illinois | מגייס |
| Mid Florida Cancer Centers | Orange City | Florida | מגייס |
| Ventura County Hematology Oncology Specialists | Oxnard | California | מגייס |
| Oregon Health & Science University (OHSU) | Portland | Oregon | מגייס |
| Virginia Cancer Institute | Richmond | Virginia | מגייס |
| Mayo Clinic | Rochester | Minnesota | מגייס |
| Medical Oncology Associates of San Diego (MOASD) | San Diego | California | מגייס |
| Medical Oncology Associates of San Diego | San Diego | California | מגייס |
| Guthrie Foundation | Sayre | Pennsylvania | מגייס |
| New York Cancer & Blood Specialists | Shirley | New York | מגייס |
| Christus Health Highlands | Shreveport | Louisiana | מגייס |
| Highlands Oncology Group (HOG) | Springdale | Arkansas | מגייס |
| Cox Health | Springfield | Missouri | מגייס |
| Comprehensive Hematology Oncology (CHO) | St. Petersburg | Florida | מגייס |
| Stockton Hematology Oncology Med Group | Stockton | California | מגייס |
| Northwest Medical Specialties (NWMS) | Tacoma | Washington | מגייס |
| Christus St. Michael's | Texarkana | Texas | מגייס |
| Cotton O'Neil Cancer Center [Stormont Vail] | Topeka | Kansas | מגייס |
| Oklahoma Cancer Specialists and Research Institute (OCSRI) | Tulsa | Oklahoma | מגייס |
| Carle Health | Urbana | Illinois | מגייס |
| Cancer Center of Kansas | Wichita | Kansas | מגייס |
| Regional Medical Oncology Center | Wilson | North Carolina | מגייס |
| Cancer Care Associates of York (CCAY) | York | Pennsylvania | מגייס |
מסמכי המחקר
לא צורפו מסמכים ברשומת מרשם זו.
שינויים לאורך זמן
- 24 בספטמבר 2026
אתר נוסף
45 sites added (47 total)
247